Of note, antagonistic regulation of Fibulin 2 cleavage by ADAMTS5 and ADAMTS12 has been previously reported to promote invasive behaviour in breast cancer cells, potentially through production of bioactive Fibulin 2 proteolytic products [194]. This evidence concerns the gene FBLN2 and breast carcinoma.